Condition
Longevity clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Longevity clinical trials that are recruiting, at sites in 3 countries (most in United States (3), Austria (2), Mexico (1)). By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Longevity clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Observational Registry for Dezawa MuseCells Outcomes | — | North Palm Beach, Florida and 1 other locations | Recruiting | Jun 12, 2026 |
| L‑serine supplements with or without strength training for older adults | — | Vienna, State of Vienna | Recruiting | Mar 12, 2026 |
| Daily collagen peptides for cellular aging in middle-aged adults | — | Vienna, State of Vienna | Recruiting | Mar 6, 2026 |
| Kaempferol absorption and pharmacokinetics in healthy adults | — | New York, New York and 2 other locations | Recruiting | Jan 7, 2026 |
| Keeping weight off after stopping GLP-1s using metformin with or without rapamycin or low‑dose naltrexone | Phase 2/3 | Chicago, Illinois | Recruiting | Jul 30, 2025 |
All recruiting trials (5)
-
Observational Registry for Dezawa MuseCells Outcomes
This project follows people who were treated with Dezawa MuseCells to see how they’re doing over 5 years using online surveys.
-
L‑serine supplements with or without strength training for older adults
This trial tries daily L‑serine supplements, alone or combined with supervised strength training, to see if they improve thinking, brain health, and physical fitness in healthy 65–85‑year‑olds.
-
Daily collagen peptides for cellular aging in middle-aged adults
This trial will test whether taking daily collagen peptides for 24 weeks can stabilize or lengthen telomeres and improve cellular aging markers in adults aged 50–70 with overweight and low-to-moderate physical activity.
-
Kaempferol absorption and pharmacokinetics in healthy adults
This trial will test how oral kaempferol is absorbed and processed in healthy adults by measuring levels in blood and urine.
-
Keeping weight off after stopping GLP-1s using metformin with or without rapamycin or low‑dose naltrexone
This trial will test whether metformin alone or combined with low‑dose rapamycin or low‑dose naltrexone helps adults 40–85 maintain weight loss after they stop GLP‑1 medications.
Related topics
Quick answers
How many Longevity clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), Austria (2 trials), Mexico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.